|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | P.O. BOX 32861 |
Address2 |
|
City | CHARLOTTE |
State | NC |
Zip Code | 28232-2861 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 58534-12
|
||||||||
|
6. House ID# 352080000
|
TYPE OF REPORT | 8. Year | 2021 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Martha Ann McConnell |
Date | 7/20/2021 2:50:57 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Any bill(s), provision(s), or action(s) impacting the 340B Drug Discount Program and hospitals and health systems ability to provide access to these drugs for patients.
Any bill(s) or provision(s) addressing high drug prices.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Martha Ann |
McConnell |
|
|
|
Kristen |
Morris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Any COVID-19 stimulus bill(s), package(s), or provision(s) impacting hospitals and health systems, including but not limited to:
Forgiveness for Medicare accelerated payments;
Additional money and reporting requirements for the Provider Relief Fund;
Support for front-line caregivers;
Liability protections for front-line medical providers and facilities;
Maintaining health benefits for individuals and families and increasing coverage options for the uninsured;
Expansion of resources for testing, tracing, and vaccine development; and
Expansion of resources for vaccine rollout and administration.
Any requirement(s) for hospitals to collect and report COVID-19 data.
Any bill(s) or provision(s) urging the delay of CMSs hospital transparency rule requiring hospitals to publicly disclose negotiated rates with commercial health plans.
Any provision(s) on the CMS hospital inpatient prospective payment system proposed rule for fiscal year 2021.
Any provision(s) on the CMS hospital outpatient prospective payment system/ ambulatory surgical center proposed rule reducing payment rates received by hospitals.
Any bill(s), provision(s), or action(s) impacting the 340B Drug Discount Program and hospitals and health systems ability to provide access to these drugs for patients.
Any bill(s) or provision(s) addressing high drug prices.
Any bill(s) or provision(s) addressing surprise medical billing proposals harmful to patients and hospitals/health systems. The No Surprises Act.
Any bill(s) or provision(s) enabling or making it easier for providers to use telemedicine to increase access for patients.
Any provision(s) expanding telehealth services and access. S. 368 THE TELEHEALTH MODERNIZATION ACT; S. 1998. PROTECTING RURAL TELEHEALTH ACCESS ACT.
Any provision(s) concerning CMSs Medicaid Fiscal Accountability Proposed Rule, with hospitals urging the proposed rule be withdrawn.
Any issue(s) related to Medicare pass-through funding and other payment technicalities in relation to colleges of nursing and allied health professions.
Any bill(s) or provision(s) addressing Medicaid Disproportionate Share Hospital (DSH) cuts, namely having to do with a delay in cuts.
Any bill(s) or provision(s) addressing access to mental health care for patients.
Any bill(s) or provision(s) addressing access to rural health care for patients.
H.R. 315, S. 748, or any other bill(s) or provision(s) addressing the elimination of Medicare sequester cuts during the COVID-19 public health emergency.
H.R. 340. INCENTIVIZING MEDICAID EXPANSION ACT OF 2021, or any other bill(s) or provision(s) addressing the expansion of Medicaid and increasing the level of Federal matching assistance for states that choose to expand Medicaid coverage.
Any bill(s) or provision(s) relating to funding for the Atrium Health/Wake Forest Baptist Innovation Quarter and Innovation Corridor.
Any bill(s) or provision(s) relating to funding/support for the Atrium Health/Wake Forest Baptist School of Medicine.
H.R.959/S. 346- BLACK MATERNAL HEALTH MOMNIBUS ACT OF 2021. Any provision(s) to help close disparities in material health outcomes.
S.1931. SURFACE TRANSPORTATION REAUTHORIZATION ACT OF 2021. Any provision(s) related to funding for health care infrastructure.
H.R.7616 - TRANSPORTATION, HOUSING AND URBAN DEVELOPMENT, AND RELATED AGENCIES APPROPRIATIONS ACT, 2021. Any provision(s) related to funding for health care infrastructure.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Martha Ann |
McConnell |
|
|
|
Kristen |
Morris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Any COVID-19 stimulus bill(s), package(s), or provision(s) impacting hospitals and health systems, including but not limited to: Forgiveness for Medicare accelerated payments; Additional money and reporting requirements for the Provider Relief Fund; Support for front-line caregivers; Liability protections for front-line medical providers and facilities; Maintaining health benefits for individuals and families and increasing coverage options for the uninsured; Expansion of resources for testing, tracing, and vaccine development; and Expansion of resources for vaccine rollout and administration.
Any bill(s) or provision(s) advocating for more PPE and supplies for healthcare workers, hospitals, and health systems during the COVID-19 pandemic.
H.R. 340. INCENTIVIZING MEDICAID EXPANSION ACT OF 2021, or any other bill(s) or provision(s) addressing the expansion of Medicaid and increasing the level of Federal matching assistance for states that choose to expand Medicaid coverage.
Any bill(s) or provision(s) relating to funding for the Atrium Health/Wake Forest Baptist Innovation Quarter and Innovation Corridor.
Any bill(s) or provision(s) relating to funding/support for the Atrium Health/Wake Forest Baptist School of Medicine.
S.1931. SURFACE TRANSPORTATION REAUTHORIZATION ACT OF 2021. Any provision(s) related to funding for health care infrastructure.
H.R.7616 - TRANSPORTATION, HOUSING AND URBAN DEVELOPMENT, AND RELATED AGENCIES APPROPRIATIONS ACT, 2021. Any provision(s) related to funding for health care infrastructure.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Martha Ann |
McConnell |
|
|
|
Kristen |
Morris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Any COVID-19 stimulus bill(s), package(s), or provision(s) impacting hospitals and health systems, including but not limited to:
Forgiveness for Medicare accelerated payments;
Additional money and reporting requirements for the Provider Relief Fund;
Support for front-line caregivers;
Liability protections for front-line medical providers and facilities;
Maintaining health benefits for individuals and families and increasing coverage options for the uninsured;
Expansion of resources for testing, tracing, and vaccine development; and
Expansion of resources for vaccine rollout and administration.
Any bill(s) or provision(s) advocating for more PPE and supplies for healthcare workers, hospitals, and health systems during the COVID-19 pandemic.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Martha Ann |
McConnell |
|
|
|
Kristen |
Morris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Any bill(s) or provision(s) urging the delay of CMSs hospital transparency rule requiring hospitals to publicly disclose negotiated rates with commercial health plans.
Any provision(s) on the CMS hospital inpatient prospective payment system proposed rule for fiscal year 2021.
Any provision(s) on the CMS hospital outpatient prospective payment system/ ambulatory surgical center proposed rule reducing payment rates received by hospitals.
Any provision(s) concerning CMSs Medicaid Fiscal Accountability Proposed Rule, with hospitals urging the proposed rule be withdrawn.
Any issue(s) related to Medicare pass-through funding and other payment technicalities in relation to colleges of nursing and allied health professions.
Any bill(s) or provision(s) addressing Medicaid Disproportionate Share Hospital (DSH) cuts, namely having to do with a delay in cuts.
H.R. 315, S. 748, or any other bill(s) or provision(s) addressing the elimination of Medicare sequester cuts during the COVID-19 public health emergency.
H.R. 340. INCENTIVIZING MEDICAID EXPANSION ACT OF 2021, or any other bill(s) or provision(s) addressing the expansion of Medicaid and increasing the level of Federal matching assistance for states that choose to expand Medicaid coverage.
Any bill(s) or provision(s) enabling or making it easier for providers to use telemedicine to increase access for patients. Any provision(s) expanding telehealth services and access. S. 368 THE TELEHEALTH MODERNIZATION ACT; S. 1998. PROTECTING RURAL TELEHEALTH ACCESS ACT.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Martha Ann |
McConnell |
|
|
|
Kristen |
Morris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TEC
16. Specific lobbying issues
Any bill(s) or provision(s) enabling or making it easier for providers to use telemedicine to increase access for patients.
S. 4794 A BILL MAKING EMERGENCY SUPPLEMENTAL APPROPRIATIONS FOR THE COVID-19 TELEHEALTH PROGRAM OF THE FEDERAL COMMUNICATIONS COMMISSION FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2020. Any provision(s) expanding telehealth services and access.
S. 368 THE TELEHEALTH MODERNIZATION ACT. Any provision(s) expanding telehealth services and access.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Martha Ann |
McConnell |
|
|
|
Kristen |
Morris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |